These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25303291)

  • 21. The role of the MTHFR C677T polymorphism in methotrexate-induced toxicity in pediatric osteosarcoma patients.
    Lambrecht L; Sleurs C; Labarque V; Dhooge C; Laenen A; Sinnaeve F; Renard M; Uyttebroeck A
    Pharmacogenomics; 2017 Jun; 18(8):787-795. PubMed ID: 28592186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study.
    Karagas MR; Park S; Nelson HH; Andrew AS; Mott L; Schned A; Kelsey KT
    Int J Hyg Environ Health; 2005; 208(5):321-7. PubMed ID: 16217917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of
    Karschnia P; Kurz SC; Brastianos PK; Winter SF; Gordon A; Jones S; Pisapia M; Nayyar N; Tonn JC; Batchelor TT; Plotkin SR; Dietrich J
    Neurology; 2023 Oct; 101(17):e1741-e1746. PubMed ID: 37527941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.
    Toffoli G; Russo A; Innocenti F; Corona G; Tumolo S; Sartor F; Mini E; Boiocchi M
    Int J Cancer; 2003 Jan; 103(3):294-9. PubMed ID: 12471611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia.
    Eissa DS; Ahmed TM
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):181-8. PubMed ID: 23183238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetics of methotrexate in pediatric hematological neoplasm treatment: does it need a personalized regimen based on MTHFR polymorphisms?
    D'Angelo V; Ramaglia M; Iannotta A; Addeo R
    Expert Rev Hematol; 2014 Oct; 7(5):517-9. PubMed ID: 25213457
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma.
    Shimasaki N; Mori T; Samejima H; Sato R; Shimada H; Yahagi N; Torii C; Yoshihara H; Tanigawara Y; Takahashi T; Kosaki K
    J Pediatr Hematol Oncol; 2006 Feb; 28(2):64-8. PubMed ID: 16462575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of methylenetetrahydrofolate reductase gene polymorphisms on homocysteine concentrations after nitrous oxide anesthesia.
    Nagele P; Zeugswetter B; Wiener C; Burger H; Hüpfl M; Mittlböck M; Födinger M
    Anesthesiology; 2008 Jul; 109(1):36-43. PubMed ID: 18580170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms are associated with differential apoptosis of leukemic B cells in vitro and disease progression in chronic lymphocytic leukemia.
    Nückel H; Frey UH; Dürig J; Dührsen U; Siffert W
    Leukemia; 2004 Nov; 18(11):1816-23. PubMed ID: 15385937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis.
    Kurzawski M; Pawlik A; Safranow K; Herczynska M; Drozdzik M
    Pharmacogenomics; 2007 Nov; 8(11):1551-9. PubMed ID: 18034620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphology and Progression in Primary Varicose Vein Disorder Due to 677C>T and 1298A>C Variants of MTHFR.
    Wilmanns C; Cooper A; Wockner L; Katsandris S; Glaser N; Meyer A; Bartsch O; Binder H; Walter PK; Zechner U
    EBioMedicine; 2015 Feb; 2(2):158-64. PubMed ID: 26137554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uridine diphosphoglucuronosyl transferase and methylenetetrahydrofolate reductase polymorphisms as genomic predictors of toxicity and response to irinotecan-, antifolate- and fluoropyrimidine-based chemotherapy.
    Toffoli G; Cecchin E
    J Chemother; 2004 Nov; 16 Suppl 4():31-5. PubMed ID: 15688606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma.
    Linnebank M; Moskau S; Jürgens A; Simon M; Semmler A; Orlopp K; Glasmacher A; Bangard C; Vogt-Schaden M; Urbach H; Schmidt-Wolf IG; Pels H; Schlegel U
    Neuro Oncol; 2009 Feb; 11(1):2-8. PubMed ID: 18806228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants.
    D'Angelo V; Ramaglia M; Iannotta A; Crisci S; Indolfi P; Francese M; Affinita MC; Pecoraro G; Napolitano A; Fusco C; Oreste M; Indolfi C; Casale F
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1339-46. PubMed ID: 21590445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between methotrexate efficacy & toxicity with C677T polymorphism of the methylenetetrahydrofolate gene in rheumatoid arthritis patients on folate supplementation.
    Aggarwal P; Naik S; Mishra KP; Aggarwal A; Misra R
    Indian J Med Res; 2006 Nov; 124(5):521-6. PubMed ID: 17213520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population.
    Cáliz R; del Amo J; Balsa A; Blanco F; Silva L; Sanmarti R; Martínez FG; Collado MD; Ramirez Mdel C; Tejedor D; Artieda M; Pascual-Salcedo D; Oreiro N; Andreu JL; Graell E; Simon L; Martínez A; Mulero J
    Scand J Rheumatol; 2012 Feb; 41(1):10-4. PubMed ID: 22044028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxic encephalopathy and delayed MTX clearance after high-dose methotrexate therapy in a child homozygous for the MTHFR C677T polymorphism.
    Müller J; Kralovánszky J; Adleff V; Pap E; Németh K; Komlósi V; Kovács G
    Anticancer Res; 2008; 28(5B):3051-4. PubMed ID: 19031955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered expression of methylenetetrahydrofolate reductase modifies response to methotrexate in mice.
    Celtikci B; Leclerc D; Lawrance AK; Deng L; Friedman HC; Krupenko NI; Krupenko SA; Melnyk S; James SJ; Peterson AC; Rozen R
    Pharmacogenet Genomics; 2008 Jul; 18(7):577-89. PubMed ID: 18551038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylenetetrahydrofolate reductase genetic polymorphisms in patients with primary open-angle glaucoma.
    Zetterberg M; Tasa G; Palmér MS; Juronen E; Toover E; Blennow K; Zetterberg H
    Ophthalmic Genet; 2007 Jun; 28(2):47-50. PubMed ID: 17558844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of MTHFR genetic polymorphisms on adverse reactions after methotrexate in patients with hematological malignancies: a meta-analysis.
    Yao P; He X; Zhang R; Tong R; Xiao H
    Hematology; 2019 Dec; 24(1):10-19. PubMed ID: 30024839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.